Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
H.R. 8205
This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases.
Read the full summary in the Pocket Congress app.